Thinking and Memory in Long-Term Lymphoma Survivors
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study looks at how well long-term lymphoma survivors' thinking and memory are working. It is for people who are 3 to 5 years after finishing their first chemotherapy and are in remission. The goal is to understand how the treatment may have affected brain function.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have had either Hodgkin lymphoma or certain types of B-cell lymphoma (like diffuse large B-cell or primary mediastinal B-cell).
- Your cancer is in complete remission after your first chemotherapy that included an anthracycline drug (like doxorubicin), and you may have also had radiation.
- You are between 25 and 55 years old.
- You are currently between 3 and 5 years after finishing your first treatment.
- You do not have signs that your lymphoma has come back.
- You have never had lymphoma in your brain or spinal cord, and you have not had radiation to your brain or spine.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a structured lifestyle and survivorship care plan for people who finished treatment for certain lymphoma types and are now in long-term remission. The goal is to support long-term health (including heart-related monitoring) and reduce future risks.
This study looks at how CAR-T cell therapy for certain types of lymphoma may affect thinking and memory. It helps doctors understand and support patients' brain health during treatment.
This study looks at how biological aging and inflammation affect people with Hodgkin's lymphoma who have finished their first treatment and are in remission. It may help doctors understand long-term health and follow-up needs.
This study measures thinking and memory skills in women who finished breast cancer treatment. Researchers want to understand how cancer treatment affects the brain and develop better support for survivors.
This study looks at how thinking and memory may be affected in people newly diagnosed with a type of lymphoma called diffuse large B-cell lymphoma (DLBCL) who are about to start a common chemotherapy regimen known as R-CHOP. It also includes a comparison group of healthy relatives. The goal is to understand how treatment may affect cognitive function over time.
This study looks at how whole-brain radiation affects thinking, memory, and other brain function in people with blood cancers that involve the brain. It may help doctors understand what to expect and which supportive treatments or monitoring could be useful.
Hear when a new Classic Hodgkin Lymphoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.